• HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • Taltz Eases Disease Activity, Improves Quality of Life in nr-axSpA Patients, Phase 3 Trial Shows
  • Rinvoq Pills Effectively Ease Symptoms in Hard-to-treat AS Patients, Phase 2/3 Trial Finds
  • Cosentyx Reduces Disease Activity and Pain in nr-axSpA Patients, Phase 3 Trial Shows
  • FDA Approves Abrilada, Biosimilar to Humira, for Adults with Ankylosing Spondylitis and Other Disorders
  • Erelzi Safe in AS, Eases Disease Activity in Rheumatoid Arthritis, Real-World Data Show
  • Rare Disease Film Festival Highlights Patient and Researcher Unity
  • Biogen Acquires Option for 5-year Extension on EU Marketing of Biosimilars for Ankylosing Spondylitis
  • Bimekizumab Found to be Safe and Show Sustained Efficacy for AS Treatment in Phase 2b Trial
  • Continuous Use of NSAIDs Increases Hypertension Risk in AS Patients, Study Suggests
  • Women Stop Using TNF Inhibitors Earlier and Switch More Often Than Do Men, Dutch Study Reports
  • Likelihood of Gout May Be More Common in AS Patients, Study Reports